维生素D与COVID-19的共识与争议方面
国际维生素D争议会议第五次年会于2021年9月15日至18日在意大利斯特雷萨举行,专家们回顾并讨论了维生素D、SARS-CoV-2感染和COVID-19领域的争议话题。会议达成共识:低25(OH)D水平与COVID-19不良结局的关联证据较为一致但发表异质;维生素D补充可能对COVID-19预防有积极作用;支持维生素D治疗降低COVID-19并发症风险的证据存在矛盾;关于有益效果的确定性结论尚待高质量随机对照试验。
要点
- 低25(OH)D水平与COVID-19不良结局的关联证据较为一致,但发表异质。
- COVID-19患者的低维生素D状态也可能反映反向因果关系。
- 维生素D补充可能对COVID-19预防有积极作用。
核心结论
- 低25 OH维生素D(25(OH)D)水平与COVID-19不良结局之间的关联证据较为一致,尽管发表的研究异质且质量参差不齐。
- COVID-19患者的低维生素D状态也可能反映反向因果关系。
- 维生素D补充可能对COVID-19预防有积极作用。
- 支持维生素D治疗降低COVID-19并发症风险的证据存在矛盾。
- 关于维生素D在此背景下有益效果的确定性结论尚待高质量随机对照试验。
研究设计与样本
- 国际会议「维生素D争议」系列研讨会始于2017年,汇集维生素D研究和临床实践的国际专家和领导者。
- 第五届年会于2021年9月15日至18日在意大利斯特雷萨举行。
- 会前,参与者回顾了其分配主题的现有研究,起草相关摘要,并在会议时展示其发现;面板内还讨论了此后可用的相关文献并相应更新。
- 会前,起草的摘要已被合并以准备初步文件;会议展示后,开放会议中的深入讨论达成共识;文件随后根据讨论和最新文献纳入进行修改。
主要发现
- 低25 OH维生素D(25(OH)D)水平与COVID-19不良结局之间的关联证据较为一致,尽管发表的研究异质且质量参差不齐。
- COVID-19患者的低维生素D状态也可能反映反向因果关系。
- 维生素D补充可能对COVID-19预防有积极作用。
- 支持维生素D治疗降低COVID-19并发症风险的证据存在矛盾。
- 关于维生素D在此背景下有益效果的确定性结论尚待高质量随机对照试验。
局限性
- 发表的研究异质且质量参差不齐。
- COVID-19患者的低维生素D状态也可能反映反向因果关系。
- 支持维生素D治疗降低COVID-19并发症风险的证据存在矛盾。
- 关于维生素D有益效果的确定性结论尚待高质量随机对照试验。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: This work aims to review and discuss controversial topics in the field of vitamin D, SARS-CoV-2 infection, and COVID-19. METHODS: The International Conferences "Controversies in Vitamin D" are a series of workshops that started in 2017 featuring international experts and leaders in vitamin D research and clinical practice. The fifth annual conference was held in Stresa, Italy, September 15 to 18, 2021. EVIDENCE: Before the event, participants reviewed available studies on their assigned topic, drafted a related abstract, and presented their findings at the time of the conference. Relevant literature that became available since was also discussed within the panel and updated accordingly. CONSENSUS: Before the event, the drafted abstracts had been merged to prepare a preliminary document. After the conference presentations, in-depth discussions in open sessions led to consensus. The document was subsequently modified according to discussions and up-to-date literature inclusion. CONCLUSIONS: There is quite consistent evidence for an association between low 25 OH vitamin D (25(OH)D) levels and poor COVID-19 outcomes, despite heterogeneous publications of variable quality. However, the low vitamin D status in COVID-19 patients might also reflect reverse causality. Vitamin D supplementation might have a positive role in COVID-19 prevention. The evidence supporting a beneficial effect of vitamin D treatment in decreasing the risk of COVID-19 complications is conflicting. Conclusive statements regarding the beneficial effect of vitamin D in this context await high-quality, randomized controlled trials.
引用
- Bilezikian JP, Binkley N, De Luca HF, et al. Consensus and Controversial Aspects of Vitamin D and COVID-19. J Clin Endocrinol Metab. 2023. PMID: 36477486. doi:10.1210/clinem/dgac719
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。